Walleye Capital LLC Ligand Pharmaceuticals Inc Put Options Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $231,560 - $308,308	2,800 New	2,800 $280,000
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $277,592 - $406,728	5,600 New	5,600 $399,000
Q4 2022 Feb 14, 2023	SELL	$61.72 - $96.74 $12,344 - $19,348	-200 Reduced 50.0%	200 $13,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $4 - $43,024	400 New	400 $34,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.